FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/044895 [Registered on: 24/08/2022] Trial Registered Prospectively
Last Modified On: 24/08/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal]  
Study Design  Single Arm Study 
Public Title of Study   Safety assessment of skin care formulation  
Scientific Title of Study   Evaluation of irritation potential of Skin Care Formulations on healthy human subjects  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
D01-6Q22-TE-JY22; Version: 01; Dated: 28/07/2022   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil 
Designation  Investigator  
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel Mumbai (Suburban) MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191   
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil 
Designation  Investigator  
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel Mumbai (Suburban) MAHARASHTRA 400013 India


MAHARASHTRA
400013
India 
Phone  02243349191   
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Lalvani  
Designation  Study Director  
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd.  
Address  3rd Floor, Kohinoor Estate, Sun Mill compound, Lower Parel Mumbai (Suburban) MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191   
Fax    
Email  mohit.CTRI@gmail.com  
 
Source of Monetary or Material Support  
MASCOT-SPINCONTROL India Pvt. Ltd. Kohinoor Estate, 3rd Floor Sun Mill Compound, Lower Parel – West, Mumbai – 400013,MAHARASHTRA, INDIA  
 
Primary Sponsor  
Name  TTK Healthcare limited Consumer product division  
Address  PROTECTIVE DEVICES DIVISION Research and Development No.3, Thiruneermalai Road, Chrompet, Chennai-600 044, Tamil Nadu, India 
Type of Sponsor  Other [FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil   Mascot Spincontrol India Pvt. Ltd.   Mascot Spincontrol India Pvt. Ltd. Kohinoor Estate, 3rd Floor Sun Mill Compound, Lower Parel – West, Mumbai – 400013,MAHARASHTRA, INDIA Mumbai MAHARASHTRA
Mumbai
MAHARASHTRA 
02243349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Normal skin type  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  MsChief Classic Natural Lubricant (MCLUF-002)  The product is leave on product. the product is loaded onto the filter paper disc in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit . This is a single application and the occluded patch is removed after 24 hours.  
Intervention  MsChief Tea & Peach Natural Lubricant (MCLTP-003)   The product is leave on product. the product is loaded onto the filter paper disc in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit . This is a single application and the occluded patch is removed after 24 hours. 
Intervention  MsChief Vanilla & Citrus Natural Lubricant (MCLVC-001)  The product is leave on product. the product is loaded onto the filter paper disc in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit . This is a single application and the occluded patch is removed after 24 hours. 
Intervention  MsChief Ylang Ylang Natural Lubricant (MCLYY-003)   The product is leave on product. the product is loaded onto the filter paper disc in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit . This is a single application and the occluded patch is removed after 24 hours. 
Comparator Agent  Negative Control (0.9% Isotonic saline solution)   0.9% Isotonic Saline Solution is dispensed in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit. This is a single application and the occluded patch is removed after 24 hours.  
Comparator Agent  Positive Control (1% w/w SLS)  1% Solution of SLS is prepared in distilled water and is dispensed in the aluminium chambers of the patch and applied on the back of the volunteers at T0 visit. This is a single application and the occluded patch is removed after 24 hours.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Healthy Human Subjects
2) is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).
3) Subjects willing to come for regular follow up and ready to follow instructions during the study period.  
 
ExclusionCriteria 
Details  For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, Psoriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having rhinitis, allergic conjunctivitis or rhinosinusitis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Dermatological safety / Irritation potential on skin   Baseline,24 hrs and 7 days  
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/08/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="8" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: To evaluate the irritation potential on healthy human subjects of skin Care Formulations.

Duration of study: 8 days study

Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application)

                  T1(Patch removal, Evaluation of test sites by Dermatologist

                 T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal),                   

T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population: 24 healthy subjects (12 males + 12 females)

The test area is checked for erythema and oedema caused due to the products and compared with positive control.

 

 
Close